CymitQuimica logo

CAS 1010100-07-8

:

CC-885

Description:
CC-885, with the CAS number 1010100-07-8, is a small molecule that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is primarily recognized as a selective inhibitor of the protein degradation pathway, specifically targeting the cereblon (CRBN) E3 ubiquitin ligase complex. This compound has shown promise in preclinical studies for its ability to modulate protein homeostasis and induce the degradation of specific oncoproteins, making it a candidate for cancer treatment. CC-885's mechanism of action involves disrupting the interaction between CRBN and its substrates, leading to the targeted degradation of proteins that contribute to tumorigenesis. Additionally, its chemical structure includes features that enhance its bioavailability and selectivity, which are critical for minimizing off-target effects. Ongoing research aims to further elucidate its pharmacokinetic properties, efficacy, and safety profile in various cancer models, paving the way for potential clinical applications.
Formula:C22H21ClN4O4
InChI:InChI=1S/C22H21ClN4O4/c1-12-2-4-15(9-17(12)23)25-22(31)24-10-13-3-5-16-14(8-13)11-27(21(16)30)18-6-7-19(28)26-20(18)29/h2-5,8-9,18H,6-7,10-11H2,1H3,(H2,24,25,31)(H,26,28,29)
InChI key:DOEVCIHTTTYVCC-UHFFFAOYSA-N
SMILES:CC1=C(C=C(C=C1)NC(=O)NCC2=CC3=C(C=C2)C(=O)N(C3)C4CCC(=O)NC4=O)Cl
Synonyms:
  • Urea, N-(3-chloro-4-methylphenyl)-N'-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]-
  • 1-(3-Chloro-4-methylphenyl)-3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)urea
Found 6 products.
  • CC-885

    CAS:
    CC-885
    Formula:C22H21ClN4O4
    Purity:99.5%
    Molecular weight:440.88

    Ref: 54-BUP04187

    1mg
    81.00€
    5mg
    186.00€
    10mg
    246.00€
    25mg
    437.00€
    50mg
    645.00€
    100mg
    948.00€
  • CC-885

    CAS:
    CC-885 is a modulator of cereblon (CRBN). It has potent anti-tumour activity.
    Formula:C22H21ClN4O4
    Purity:99.08% - 99.83%
    Color and Shape:Solid
    Molecular weight:440.88
  • N-(3-chloro-4-methylphenyl)-N'-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1-oxo-1H-isoindol-5-yl]methyl]-urea

    CAS:
    Formula:C22H21ClN4O4
    Purity:98%
    Color and Shape:Solid
    Molecular weight:440.8795

    Ref: IN-DA01EPNZ

    25mg
    156.00€
    50mg
    211.00€
    100mg
    223.00€
    250mg
    332.00€
    1g
    546.00€
    5g
    1,504.00€
  • 1-(3-Chloro-4-methylphenyl)-3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)urea

    CAS:
    1-(3-Chloro-4-methylphenyl)-3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)urea
    Formula:C22H21ClN4O4
    Purity:99%
    Molecular weight:440.88
  • CC-885

    CAS:
    Purity:98%
    Molecular weight:440.125

    Ref: 10-F549587

    50mg
    190.00€
    100mg
    257.00€
    250mg
    327.00€
    1g
    799.00€
  • CC-885

    CAS:

    CC-885 is a pharmacologic agent that inhibits the ubiquitin ligases, which are enzymes that catalyze the transfer of ubiquitin to proteins. CC-885 has been shown to increase the levels of ubiquitinated proteins in cells and to inhibit their degradation by the proteasome. This drug has been shown to alter translation and cellular response pathways, leading to a clinical response in patients with chronic lymphocytic leukemia (CLL). It also acts as an immunomodulatory drug for lymphocytic leukemia, inhibiting transcriptional activation of NF-κB and NFAT in T cells. CC-885 is being developed for use as a cancer therapeutic agent. The mechanism of action is not fully understood, but it may be due to its ability to inhibit DNA replication or induce apoptosis.

    Formula:C22H21ClN4O4
    Purity:Min. 95%
    Molecular weight:440.88 g/mol

    Ref: 3D-KQB10007

    50mg
    507.00€
    500mg
    1,388.00€